Amgen Inc. (NASDAQ:AMGN) is one of the high-margin pharma stocks to buy now. HSBC has lowered its price target on Amgen Inc.

President Trump is reportedly pushing for higher blanket tariffs on imports from the European Union, throwing a wrench in ...

The expiration of the enhanced ACA premium subsidies at the end of this year is prompting many insurers to hike rates by an ...

Despite former President Donald Trump’s threat of a 200% tariff on imported drugs during a cabinet meeting, pharmaceutical investors have shown surprisingly positive sentiment this week. Despite ...

Bessent's victory lap on tariff revenues was premature. And so are hopes that the trade war won't damage commerce and the U.S. economy.

The average consumer could pay 75 percent more for a marketplace plan, according to a KFF analysis, driven by the expiration ...

People who get health insurance through the Affordable Care Act could soon see their monthly premiums sharply increase as ...

The opening salvo of second-quarter earnings calls this week came against President Donald Trump’s renewed calls for a tariff ...

Finally, don't discount legal challenges to the president's tariffs. An argument could be made that pharmaceutical products ...

The pharmaceutical sector continues to stand out as a resilient and highly profitable corner of the market, even amid global ...

The pharmaceutical company raised its full-year profit guidance as ongoing demand for key drugs fueled growth in ...

Stocks rose Thursday as investors responded to a flurry of quarterly earnings reports from major companies and better-than-expected retail sales data.